What about Kaufman resignation as Chairman. And he sold his shares?? Where did Ghosh go- he was chief scientist in first version of PAR before he disappeared to be replaced by unsuccessful rhinitis team. Did he argue with PR? Is the bene plant Christian Reiter still on the team in Australia? How can PR claim to be an innovator in such a highly technical environment as drug discovery- he is from marketing
Too many unanswered questions after over 10 years and still waiting for dose response study- a phase 2 study which has to be complete before phase 3 starts in dozens of centres- each costing hundreds of thousands of commitment per site. This is starting to look like a "technical ponzi scheme". IMO DYOR
Ann: Change of Chief Financial Officer, page-38
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.015(6.52%) |
Mkt cap ! $85.70M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 25.0¢ | 24.0¢ | $163.9K | 674.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 518922 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 50728 | 3 |
View Market Depth
| Last trade - 11.54am 20/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |